PT2385 inhibited the expression of HIF-2α-dependent genes associated with tumor growth, including VEGF-A, PAI-1, and Cyclin D1 in ccRCC cell lines, and induced tumor regression in xenograft models [19]. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.